SHELBY LUSTER: Open Payments
NPI 1023767811 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 17 payments from 10 companies in 2025. Trend: 2023 $1,159 · 2024 $295 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 5 | $126 |
| Exact Sciences Corporation | 1 | $120 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| PROTEGA PHARMACEUTIALS INC | 3 | $46 |
| Organon LLC | 1 | $45 |
| Novo Nordisk Inc | 2 | $34 |
| Lilly USA, LLC | 1 | $19 |
| Insulet Corporation | 1 | $19 |
| Boston Scientific Corporation | 1 | $18 |
| Averitas Pharma Inc. | 1 | $16 |
Products named: Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, AREXVY, ROXYBOND, NEXPLANON, MOUNJARO, Omnipod, WATCHMAN FLX.
Industry payments across MO — which companies pay providers there.
